Global Liver Institute

Liver Matters

GLOBAL LIVER INSTITUTE

Liver Matters
Policy, Prevention, and Progress: Fatty Liver & Obesity

Policy, Prevention, and Progress: Fatty Liver & Obesity

Dr. Kelly Brownell, Dean Emeritus of the Sanford School of Public Policy at Duke University, has over 35 years of experience studying food systems and obesity. After initially focusing on obesity treatments, he found that weight loss often led to rapid regain, suggesting a harmful metabolic change.

read more
Perils of AI in Healthcare

Perils of AI in Healthcare

As the founder and CEO of Global Liver Institute (GLI), and a liver transplant patient myself, I know it is imperative to connect the dots between real-world experiences of patients and policy solutions.

read more
From Awareness to Action on Global Fatty Liver Day

From Awareness to Action on Global Fatty Liver Day

Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment of fatty liver disease to prevent its progression to chronic liver disease, cirrhosis, or cancer.

read more
The Quiet Threat of Fatty Liver in Lean Individuals

The Quiet Threat of Fatty Liver in Lean Individuals

Nonalcoholic fatty liver disease (NAFLD or more recently metabolic dysfunction-associated steatotic liver disease, MASLD) has long been associated with obesity, but researchers are beginning to look into the trend that a sizable portion of those with the disease actually has a “normal” or lean weight.

read more
Deploying Solutions: How Can Veterans Manage Fatty Liver

Deploying Solutions: How Can Veterans Manage Fatty Liver

Fatty liver disease includes a spectrum of liver conditions characterized by excess fat accumulation in the liver of individuals. It encompasses a range of conditions, from simple steatosis (fatty liver) to nonalcoholic steatohepatitis (NASH), as well as nonalcoholic fatty liver disease (NAFLD) which can progress to cirrhosis, liver failure, and hepatocellular carcinoma.

read more
Uncovering the Effects Health Inequities Have on Cancer – Liver Cancer News

Uncovering the Effects Health Inequities Have on Cancer – Liver Cancer News

Genentech/Roche is enhancing the accessibility of clinical trials by providing comprehensive patient support services. By tackling common barriers to participation – such as travel costs, distance, parking, childcare, conflicting work schedules, health literacy, site location, capabilities, expectations, and privacy concerns – they aim to make clinical trials more inclusive and representative.

read more
Global Liver Institute Applauds ​​U.S. Representative Nydia Velázquez’ Reintroduction of The Liver Illness, Visibility, Education and Research Act (LIVER Act)

Global Liver Institute Applauds ​​U.S. Representative Nydia Velázquez’ Reintroduction of The Liver Illness, Visibility, Education and Research Act (LIVER Act)

Global Liver Institute applauds U.S. Representative Nydia Velázquez (D-NY) for reintroducing this vital legislation to improve the lives of all people impacted by liver disease. GLI was proud to collaborate in the development of The Liver Illness, Visibility, Education and Research Act (LIVER Act), first introduced in 2018.

read more